Loading Events

« All Events

  • This event has passed.

Evolving Role of FLT3 Analysis in AML Diagnosis and Management: Presentation and Discussion

May 29, 2023 @ 7:00 pm - 8:00 pm EDT

Evolving Role of FLT3 Analysis in AML Diagnosis and Management: Presentation and Discussion

When: Monday, May 29, 2023, 7:00 PM EST
Where: Zoom – link will be provided upon registration

Faculty :
Julie Bergeron, MD
Hôpital Maisonneuve-Rosemont, Montreal, QC

José-Mario Capo-Chichi, PhD
University Health Network, Toronto, ON

Hubert Tsui, MD
Sunnybrook Health Sciences Centre, Toronto, ON

Questions to be addressed include:

  • What is the clinical relevance in AML of FLT3-ITD and FLT3-TKD mutations?
  • Which patients should be tested for FLT3 mutations, and when?
  • Which is the preferred method for FLT3 mutation testing?
  • What is the clinical relevance of FLT3-ITD size, insertion site and number of distinct mutations?
  • Is there a role for FLT3-ITD analysis in MRD assessment?
  • What is the clinical relevance of the FLT3-ITD allelic burden? Should it be assessed and if so, how?
  • How should results of FLT3 mutation testing be reported?

 

Details

Date:
May 29, 2023
Time:
7:00 pm - 8:00 pm EDT

Member Login